Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELTA Vaginal Suppositories for Endometriosis
NCT03481842Phase 2Withdrawn
- Sponsor
- BioGene
- Start
- Oct 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib, afatinib, linifanib in endometriosis, sponsored by BioGene. Planned start Oct 2021; status: withdrawn.
02
Drugs
axitinibafatiniblinifanib
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT03481842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03481842.